Details for Patent: 10,945,987
✉ Email this page to a colleague
Which drugs does patent 10,945,987 protect, and when does it expire?
Patent 10,945,987 protects EPSOLAY and is included in one NDA.
This patent has twelve patent family members in two countries.
Summary for Patent: 10,945,987
| Title: | Method for providing early onset of action in the treatment of rosacea |
| Abstract: | A regimen is described for providing early onset of action in the therapeutic treatment of rosacea including topically applying a pharmaceutical composition to the skin of a subject in need of said treatment. The pharmaceutical composition includes about 1% to about 10% benzoyl peroxide as the only active ingredient, and a pharmaceutically acceptable carrier or excipient. The pharmaceutical composition is applied once daily for a period of at least about 2, 4, 8 or 12 weeks. Based on early onset of action, a primary measure of success is at least about 9%, primary measure of success being defined as a 2-grade improvement in IGA of clear or almost clear; and a secondary measure of success is at least about 40%, secondary measure of success being defined as mean inflammatory lesion count percent reduction from baseline, after at least about 2 weeks of treatment. |
| Inventor(s): | Toledano; Ofer (Kfar Saba, IL), Levy-Hacham; Ofra (Ness Ziona, IL), Nov; Ori (Tarum, IL), Ram; Vered (Rehovot, IL) |
| Assignee: | SOL-GEL TECHNOLOGIES LTD. (Ness Ziona, IL) |
| Application Number: | 16/794,734 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 10,945,987
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | EPSOLAY | benzoyl peroxide | CREAM;TOPICAL | 214510-001 | Apr 22, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TOPICAL TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA IN ADULTS 18 YEARS OF AGE AND OLDER | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,945,987
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3130362 | ⤷ Try a Trial | |||
| Canada | 3130437 | ⤷ Try a Trial | |||
| Canada | 3130439 | ⤷ Try a Trial | |||
| Canada | 3130441 | ⤷ Try a Trial | |||
| World Intellectual Property Organization (WIPO) | 2020170029 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
